COVID 19 repercussions in ophthalmology: a narrative review.
Thiago Goncalves Dos Santos MartinsDiogo Gonçalves Dos Santos MartinsThomaz Gonçalves Dos Santos MartinsPaula M MarinhoPaulo F G M M TiernoPublished in: Sao Paulo medical journal = Revista paulista de medicina (2021)
Knowledge of eye symptoms and ocular transmission of the virus remains incomplete. New clinical trials with larger numbers of patients may answer these questions in the future. Moreover, positively, implementation of innovative changes in medicine such as telemedicine and artificial intelligence may assist in diagnosing eye diseases and in training and education for students.
Keyphrases
- artificial intelligence
- healthcare
- clinical trial
- machine learning
- end stage renal disease
- big data
- deep learning
- sars cov
- coronavirus disease
- ejection fraction
- newly diagnosed
- chronic kidney disease
- primary care
- randomized controlled trial
- peritoneal dialysis
- current status
- study protocol
- phase ii
- optical coherence tomography
- respiratory syndrome coronavirus